YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...

Job Stress, Employee Turnover Intention, Emotional Exhaustion, Work-Life Balance, Job Demands-Resources (JD-R) Share and Cite: Shetu, S. , Akter, F. , Mostarin, M. and Nasrin, S. (2025) From Stress to ...